Log in to save to my catalogue

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication...

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d41588e312ab4eac8d154bd63dbab6a2

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics

About this item

Full title

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics

Publisher

New Zealand: Dove Medical Press

Journal title

International journal of nanomedicine, 2016-08, Vol.10 Spec Iss (Spec Iss), p.281-292

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press

More information

Scope and Contents

Contents

Advanced glycation end products (AGEs) are known to play an important role in the pathogenesis of neurodegenerative diseases, including Parkinson's disease (PD), by inducing protein aggregation and cross-link, formation of Lewy body, and neuronal death. In this study, we observed that AGE-albumin, the most abundant AGE product in the human PD brain...

Alternative Titles

Full title

Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d41588e312ab4eac8d154bd63dbab6a2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d41588e312ab4eac8d154bd63dbab6a2

Other Identifiers

ISSN

1178-2013,1176-9114

E-ISSN

1178-2013

DOI

10.2147/IJN.S95077

How to access this item